Retail sale of pharmaceutical products
HUNNDALEN APOTEK AS
Revenue 2025
NOK 3.2m
Operating profit
NOK −240,000
Equity
NOK 516,000
Incorporated
2024
Employees
7
Share capital
NOK 800,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 3.2m | |
| Total operating costs | 3.4m | |
| Operating profit (EBIT) | −240k | |
| Net financial items | −38k | |
| Profit for the year | −278k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 5.3m | |
| of which current assets | 3.0m | |
| Equity | 516k | |
| Total liabilities | 4.8m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.